NO20025674L - 5-klor-3-(4-metansulfonylfenyl)-6'-metyl-[2,3']bipyridinyl i ren, krystallinsk form og fremgangsmate for syntese - Google Patents

5-klor-3-(4-metansulfonylfenyl)-6'-metyl-[2,3']bipyridinyl i ren, krystallinsk form og fremgangsmate for syntese

Info

Publication number: NO20025674L
Authority: NO; Norway
Prior art keywords: methanesulfonylphenyl; bipyridinyl; chloro; synthesis; methyl
Prior art date: 2000-05-26

Application number

NO20025674A

Other languages

English (en)

Other versions

NO20025674D0 (no

NO324495B1 (no

Inventor

Louis S Crocker

Ian W Davies

Richard G Osifchin

Andrew Kotliar

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-26

Filing date

2002-11-26

Publication date

2002-11-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22772880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20025674(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-11-26 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2002-11-26 Publication of NO20025674D0 publication Critical patent/NO20025674D0/no

2002-11-26 Publication of NO20025674L publication Critical patent/NO20025674L/no

2007-10-29 Publication of NO324495B1 publication Critical patent/NO324495B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20025674A 2000-05-26 2002-11-26 Polymorf form av 5-klor-3-(4-metansulfonylfenyl)-6'-metyl-[2,3']bipyridinyl, farmasoytisk preparat inneholdende denne, og anvendelse av forbindelsen for fremstilling av et medikament NO324495B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20801700P	2000-05-26	2000-05-26
PCT/US2001/016566 WO2001092230A1 (en)	2000-05-26	2001-05-22	5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis

Publications (3)

Publication Number	Publication Date
NO20025674D0 NO20025674D0 (no)	2002-11-26
NO20025674L true NO20025674L (no)	2002-11-26
NO324495B1 NO324495B1 (no)	2007-10-29

Family

ID=22772880

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025674A NO324495B1 (no)	2000-05-26	2002-11-26	Polymorf form av 5-klor-3-(4-metansulfonylfenyl)-6'-metyl-[2,3']bipyridinyl, farmasoytisk preparat inneholdende denne, og anvendelse av forbindelsen for fremstilling av et medikament

Country Status (48)

Country	Link
EP (1)	EP1296951B1 (no)
JP (2)	JP3665053B2 (no)
KR (1)	KR100757699B1 (no)
CN (1)	CN1227233C (no)
AR (1)	AR028577A1 (no)
AT (1)	ATE483687T1 (no)
AU (2)	AU6480401A (no)
BG (1)	BG65855B1 (no)
BR (1)	BRPI0111140B8 (no)
CA (1)	CA2410234C (no)
CR (1)	CR6606A (no)
CY (1)	CY1111440T1 (no)
CZ (1)	CZ20023888A3 (no)
DE (1)	DE60143197D1 (no)
DK (1)	DK1296951T3 (no)
EA (1)	EA004809B1 (no)
EE (1)	EE05242B1 (no)
EG (1)	EG24189A (no)
ES (1)	ES2351958T3 (no)
GC (1)	GC0000362A (no)
GE (1)	GEP20053492B (no)
GT (1)	GT200100091A (no)
HN (1)	HN2001000110A (no)
HR (1)	HRP20020934B1 (no)
HU (1)	HU228423B1 (no)
IL (1)	IL152582A0 (no)
IN (2)	IN2002CH02089A (no)
IS (1)	IS2806B (no)
JO (1)	JO2216B1 (no)
MA (1)	MA26919A1 (no)
ME (1)	ME00428B (no)
MX (1)	MX230696B (no)
MY (1)	MY123569A (no)
NO (1)	NO324495B1 (no)
NZ (1)	NZ522394A (no)
PA (1)	PA8516901A1 (no)
PE (1)	PE20011324A1 (no)
PH (1)	PH12001001175B1 (no)
PL (1)	PL358153A1 (no)
PT (1)	PT1296951E (no)
RS (1)	RS51541B (no)
SI (1)	SI1296951T1 (no)
SK (1)	SK287174B6 (no)
SV (1)	SV2002000462A (no)
TW (1)	TWI303634B (no)
UA (1)	UA73355C2 (no)
WO (1)	WO2001092230A1 (no)
ZA (1)	ZA200209558B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6858631B1 (en)	1999-11-29	2005-02-22	Merck & Co., Inc.	Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl
EP1248618B1 (en)	1999-11-29	2006-03-22	Merck Frosst Canada Inc.	Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl
US6521642B2 (en) *	2000-05-26	2003-02-18	Merck & Co., Inc.	5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis
PL2401253T3 (pl)	2009-02-27	2016-05-31	Cadila Healthcare Ltd	Sposób otrzymywania etorykoksybu
WO2012004677A1 (en)	2010-07-05	2012-01-12	Actavis Group Ptc Ehf	Solid state forms of etoricoxib salts
EA023286B1 (ru)	2011-05-27	2016-05-31	ФАРМА ДжРС, Д.О.О.	Способ получения полиморфной формы i эторикоксиба
EP2773618A1 (en)	2011-11-03	2014-09-10	Cadila Healthcare Limited	An improved process for the preparation of etoricoxib and polymorphs thereof
WO2013075732A1 (en)	2011-11-21	2013-05-30	Synthon Bv	Process for making crystalline form i of etoricoxib
EP2601952A1 (en)	2011-12-07	2013-06-12	Zentiva, k.s.	Novel pharmaceutically acceptable salts and cocrystals of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl and their therapeutic uses
WO2014033526A1 (en)	2012-08-27	2014-03-06	Cadila Healthcare Limited	Pharmaceutical compositions of etoricoxib
EP2888231B1 (en)	2012-08-27	2019-01-09	Glenmark Pharmaceuticals Limited	Process for preparation of crystalline etoricoxib
CN104418799A (zh) *	2013-09-03	2015-03-18	天津药物研究院	一种依托考昔的晶型及其制备方法和应用
WO2015036550A1 (en)	2013-09-13	2015-03-19	Synthon B.V.	Process for making etoricoxib
CN106632003B (zh) *	2015-12-31	2019-02-12	上海博志研新药物技术有限公司	一种依托考昔的制备方法
CN108069896B (zh) *	2016-11-11	2022-08-12	昆明积大制药股份有限公司	一种依托考昔晶型的制备方法
CN107417599B (zh) *	2017-06-21	2020-06-09	四川尚锐生物医药有限公司	一种依托考昔晶型的制备方法
CN107056691B (zh) *	2017-06-21	2020-03-10	四川尚锐生物医药有限公司	一种制备依托考昔晶型v的方法
MX2017009660A (es)	2017-07-26	2017-11-23	Laboratorios Liomont S A De C V	Composicion farmaceutica con un rango de relacion entre el clorhidrato de tramadol y el etoricoxib para su administracion para el tratamiento del dolor.
CN107556231A (zh) *	2017-09-23	2018-01-09	江苏正大清江制药有限公司	一种依托考昔与对硝基苯甲酸形成的盐的晶型及制备方法
CN107417600A (zh) *	2017-09-26	2017-12-01	江苏正大清江制药有限公司	一种依托考昔与呋喃甲酸形成盐的新晶型及制备方法
CN107898787B (zh) *	2017-12-15	2018-11-30	扬子江药业集团上海海尼药业有限公司	一种药物组合物及其制剂和制备方法
MX2018013070A (es)	2017-12-29	2019-10-15	Gruenenthal Gmbh	Combinación farmacéutica que comprende clorhidrato de tramadol de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor.
CN110143915A (zh) *	2019-06-03	2019-08-20	蚌埠学院	一种依托考昔与对甲苯磺酸形成盐的新晶型及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5593994A (en) *	1994-09-29	1997-01-14	The Dupont Merck Pharmaceutical Company	Prostaglandin synthase inhibitors
US5739166A (en) *	1994-11-29	1998-04-14	G.D. Searle & Co.	Substituted terphenyl compounds for the treatment of inflammation
US5861419A (en) *	1996-07-18	1999-01-19	Merck Frosst Canad, Inc.	Substituted pyridines as selective cyclooxygenase-2 inhibitors
EP0912518B1 (en) *	1996-07-18	2003-09-10	Merck Frosst Canada & Co.	Substituted pyridines as selective cyclooxygenase-2 inhibitors
PT1071745E (pt) *	1998-04-24	2004-11-30	Merck & Co Inc	Processo para sintetizar inibidores cox-2
EP1248618B1 (en) *	1999-11-29	2006-03-22	Merck Frosst Canada Inc.	Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl

2001
- 2001-05-15 PH PH12001001175A patent/PH12001001175B1/en unknown
- 2001-05-16 AR ARP010102327A patent/AR028577A1/es unknown
- 2001-05-16 TW TW090111718A patent/TWI303634B/zh not_active IP Right Cessation
- 2001-05-16 GC GCP20011369 patent/GC0000362A/en active
- 2001-05-17 PE PE2001000443A patent/PE20011324A1/es not_active Application Discontinuation
- 2001-05-18 MY MYPI20012375 patent/MY123569A/en unknown
- 2001-05-21 GT GT200100091A patent/GT200100091A/es unknown
- 2001-05-22 EP EP01939267A patent/EP1296951B1/en not_active Expired - Lifetime
- 2001-05-22 SK SK1670-2002A patent/SK287174B6/sk not_active IP Right Cessation
- 2001-05-22 CN CNB018101372A patent/CN1227233C/zh not_active Ceased
- 2001-05-22 PT PT01939267T patent/PT1296951E/pt unknown
- 2001-05-22 CZ CZ20023888A patent/CZ20023888A3/cs unknown
- 2001-05-22 SI SI200130982T patent/SI1296951T1/sl unknown
- 2001-05-22 NZ NZ522394A patent/NZ522394A/en not_active IP Right Cessation
- 2001-05-22 JP JP2002500844A patent/JP3665053B2/ja not_active Expired - Lifetime
- 2001-05-22 ME MEP-2008-638A patent/ME00428B/me unknown
- 2001-05-22 HU HU0302336A patent/HU228423B1/hu unknown
- 2001-05-22 ES ES01939267T patent/ES2351958T3/es not_active Expired - Lifetime
- 2001-05-22 EG EG20010540A patent/EG24189A/xx active
- 2001-05-22 HR HR20020934A patent/HRP20020934B1/xx not_active IP Right Cessation
- 2001-05-22 PA PA20018516901A patent/PA8516901A1/es unknown
- 2001-05-22 GE GE5012A patent/GEP20053492B/en unknown
- 2001-05-22 JO JO200179A patent/JO2216B1/en active
- 2001-05-22 DK DK01939267.9T patent/DK1296951T3/da active
- 2001-05-22 BR BRPI0111140-0 patent/BRPI0111140B8/pt not_active IP Right Cessation
- 2001-05-22 AT AT01939267T patent/ATE483687T1/de active
- 2001-05-22 PL PL01358153A patent/PL358153A1/xx not_active Application Discontinuation
- 2001-05-22 IL IL15258201A patent/IL152582A0/xx active IP Right Grant
- 2001-05-22 UA UA20021210537A patent/UA73355C2/uk unknown
- 2001-05-22 EA EA200201264A patent/EA004809B1/ru not_active IP Right Cessation
- 2001-05-22 DE DE60143197T patent/DE60143197D1/de not_active Expired - Lifetime
- 2001-05-22 WO PCT/US2001/016566 patent/WO2001092230A1/en not_active Ceased
- 2001-05-22 AU AU6480401A patent/AU6480401A/xx active Pending
- 2001-05-22 EE EEP200200655A patent/EE05242B1/xx unknown
- 2001-05-22 AU AU2001264804A patent/AU2001264804B2/en not_active Expired
- 2001-05-22 CA CA002410234A patent/CA2410234C/en not_active Expired - Lifetime
- 2001-05-22 RS YUP-894/02A patent/RS51541B/sr unknown
- 2001-05-22 MX MXPA02011619 patent/MX230696B/es active IP Right Grant
- 2001-05-22 KR KR20027015871A patent/KR100757699B1/ko not_active Expired - Lifetime
- 2001-05-23 HN HN2001000110A patent/HN2001000110A/es unknown
- 2001-05-23 SV SV2001000462A patent/SV2002000462A/es active IP Right Grant
2002
- 2002-03-08 CR CR6606A patent/CR6606A/es unknown
- 2002-10-31 BG BG107237A patent/BG65855B1/bg unknown
- 2002-11-20 IS IS6630A patent/IS2806B/is unknown
- 2002-11-25 ZA ZA200209558A patent/ZA200209558B/en unknown
- 2002-11-26 NO NO20025674A patent/NO324495B1/no not_active IP Right Cessation
- 2002-12-16 IN IN2089CH2002 patent/IN2002CH02089A/en unknown
- 2002-12-23 MA MA26971A patent/MA26919A1/fr unknown
2004
- 2004-09-10 JP JP2004263913A patent/JP4142621B2/ja not_active Expired - Lifetime
2007
- 2007-11-12 IN IN5103CH2007 patent/IN2007CH05103A/en unknown
2011
- 2011-01-04 CY CY20111100010T patent/CY1111440T1/el unknown

Also Published As

Publication number	Publication date
NO20025674D0 (no)	2002-11-26
ZA200209558B (en)	2003-10-28
HRP20020934A2 (en)	2005-02-28
SK16702002A3 (sk)	2003-05-02
BG65855B1 (bg)	2010-03-31
JO2216B1 (en)	2004-10-07
HUP0302336A2 (hu)	2003-11-28
MX230696B (es)	2005-09-19
ME00428B (me)	2011-10-10
BR0111140A (pt)	2005-01-11
PE20011324A1 (es)	2002-01-28
PA8516901A1 (es)	2002-04-25
IL152582A0 (en)	2003-05-29
AU2001264804B2 (en)	2006-04-06
CZ20023888A3 (cs)	2003-02-12
SK287174B6 (sk)	2010-02-08
EE200200655A (et)	2004-08-16
YU89402A (sh)	2005-11-28
IS2806B (is)	2012-09-15
EA004809B1 (ru)	2004-08-26
ATE483687T1 (de)	2010-10-15
DK1296951T3 (da)	2011-01-24
CA2410234C (en)	2008-05-13
MXPA02011619A (es)	2003-03-27
EG24189A (en)	2008-10-08
NO324495B1 (no)	2007-10-29
HK1058932A1 (en)	2004-06-11
PT1296951E (pt)	2010-12-07
IN2002CH02089A (no)	2005-02-25
EP1296951B1 (en)	2010-10-06
GC0000362A (en)	2007-03-31
CR6606A (es)	2006-02-06
CN1227233C (zh)	2005-11-16
DE60143197D1 (de)	2010-11-18
EE05242B1 (et)	2009-12-15
CA2410234A1 (en)	2001-12-06
AR028577A1 (es)	2003-05-14
TWI303634B (en)	2008-12-01
AU6480401A (en)	2001-12-11
GEP20053492B (en)	2005-04-25
JP2005047927A (ja)	2005-02-24
GT200100091A (es)	2001-12-28
UA73355C2 (en)	2005-07-15
IN2007CH05103A (no)	2008-08-27
WO2001092230A1 (en)	2001-12-06
SI1296951T1 (sl)	2011-01-31
CY1111440T1 (el)	2015-08-05
JP2004501116A (ja)	2004-01-15
SV2002000462A (es)	2002-03-08
IS6630A (is)	2002-11-20
PH12001001175B1 (en)	2006-08-10
BG107237A (bg)	2003-05-30
EP1296951A1 (en)	2003-04-02
KR20030003762A (ko)	2003-01-10
RS51541B (sr)	2011-06-30
KR100757699B1 (ko)	2007-09-13
HN2001000110A (es)	2002-03-06
HU228423B1 (en)	2013-03-28
HRP20020934B1 (en)	2012-01-31
EA200201264A1 (ru)	2003-04-24
JP3665053B2 (ja)	2005-06-29
MY123569A (en)	2006-05-31
MA26919A1 (fr)	2004-12-20
BRPI0111140B1 (pt)	2018-03-13
JP4142621B2 (ja)	2008-09-03
CN1443168A (zh)	2003-09-17
PL358153A1 (en)	2004-08-09
ES2351958T3 (es)	2011-02-14
NZ522394A (en)	2004-05-28
BRPI0111140B8 (pt)	2021-05-25

Publication	Publication Date	Title
NO20025674L (no)	2002-11-26	5-klor-3-(4-metansulfonylfenyl)-6'-metyl-[2,3']bipyridinyl i ren, krystallinsk form og fremgangsmate for syntese
HUP0301651A2 (en)	2008-10-28	Indolylmaleimide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0301742A3 (en)	2005-08-29	Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use
HUP0303109A3 (en)	2010-04-28	Indolin-2-one derivatives, process for producing them and pharmaceutical compositions containing them
HUP0302230A3 (en)	2007-09-28	Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
HUP0204235A3 (en)	2005-03-29	Substituted glutarimides and use thereof il-12 production inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0500983A3 (en)	2012-09-28	Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
DK199900554A (da)	2000-01-03	Paroxetinsalte, fremgangsmåde til fremstilling deraf, farmaceutiske præparater omfattende disse og anvendelser deraf
HUP0303118A3 (en)	2007-08-28	Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0302295A3 (en)	2007-03-28	Thienodibenzoazulene derivatives, process for their preparation and use thereof
DK1138677T3 (da)	2003-09-29	Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin
HUP0400549A3 (en)	2004-09-28	Novel imidazole derivatives, production method thereof and pharmaceutical compositions containing them
PL356911A1 (en)	2004-07-12	Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
DK1122254T3 (da)	2005-08-29	4-sulfonamidpiperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
HUP0204001A3 (en)	2005-04-28	Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en)	2007-03-28	Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
AU2002223766A1 (en)	2002-05-21	Single crystals, method for making single crystals by growth in solution and uses
AU2001254812A1 (en)	2001-11-07	9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
HUP0300738A3 (en)	2004-08-30	Method for producing lhrh-peptide salts, their use, and pharmaceutical preparations containing these peptide salts
EP1372594A4 (en)	2004-04-07	KOJINIC ACID DERIVATIVES STABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF, AND THE LIGHTENING COSMETIC COMPOSITIONS CONTAINING THE SAME
HUP0101503A3 (en)	2003-02-28	Heterocycloalkyl- and heteroaryl-benzocyclobutane derivatives, process for their preparation and pharmaceutical compositions containing them
IL156160A0 (en)	2003-12-23	Klainetins and their derivatives, method for their preparation and use thereof
NO20023687D0 (no)	2002-08-02	1,3,4-oksadiazolderivater og fremgangsmåte for fremstilling derav
HU0101504D0 (en)	2001-06-28	New cyclobutaindolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL151216A0 (en)	2003-04-10	Pluraflavins and derivatives thereof, process for their preparation and use thereof

Legal Events

Date	Code	Title	Description
2021-06-07	MK1K	Patent expired